Cargando…
eBrain: a Three Dimensional Simulation Tool to Study Drug Delivery in the Brain
Neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease are severe disorders with acute symptoms that gradually progress. In the course of developing disease-modifying treatments for neurodegenerative disorders there is a need to develop novel strategies to increase efficacy of drugs...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467991/ https://www.ncbi.nlm.nih.gov/pubmed/30992468 http://dx.doi.org/10.1038/s41598-019-42261-3 |
_version_ | 1783411343185936384 |
---|---|
author | Setty, Yaki |
author_facet | Setty, Yaki |
author_sort | Setty, Yaki |
collection | PubMed |
description | Neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease are severe disorders with acute symptoms that gradually progress. In the course of developing disease-modifying treatments for neurodegenerative disorders there is a need to develop novel strategies to increase efficacy of drugs and accelerate the development process. We developed a tool for simulating drug delivery in the brain by translating MRI data into an interactive 3D model. This tool, the eBrain, superimposes simulated drug diffusion and tissue uptake by inferring from the MRI data with a seamless display from any angle, magnification, or position. We discuss a representative implementation of eBrain that is inspired by clinical data in which insulin is intranasally administered to Alzheimer patients. Using extensive analysis of multiple eBrain simulations with varying parameters, we show the potential for eBrain to determine the optimal dosage to ensure drug delivery without overdosing the tissue. Specifically, we examined the efficacy of combined drug doses and potential compounds for tissue stimulation. Interestingly, our analysis uncovered that the drug efficacy is inferred from tissue intensity levels. Finally, we discuss the potential of eBrain and possible applications of eBrain to aid both inexperienced and experienced medical professionals as well as patients. |
format | Online Article Text |
id | pubmed-6467991 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-64679912019-04-23 eBrain: a Three Dimensional Simulation Tool to Study Drug Delivery in the Brain Setty, Yaki Sci Rep Article Neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease are severe disorders with acute symptoms that gradually progress. In the course of developing disease-modifying treatments for neurodegenerative disorders there is a need to develop novel strategies to increase efficacy of drugs and accelerate the development process. We developed a tool for simulating drug delivery in the brain by translating MRI data into an interactive 3D model. This tool, the eBrain, superimposes simulated drug diffusion and tissue uptake by inferring from the MRI data with a seamless display from any angle, magnification, or position. We discuss a representative implementation of eBrain that is inspired by clinical data in which insulin is intranasally administered to Alzheimer patients. Using extensive analysis of multiple eBrain simulations with varying parameters, we show the potential for eBrain to determine the optimal dosage to ensure drug delivery without overdosing the tissue. Specifically, we examined the efficacy of combined drug doses and potential compounds for tissue stimulation. Interestingly, our analysis uncovered that the drug efficacy is inferred from tissue intensity levels. Finally, we discuss the potential of eBrain and possible applications of eBrain to aid both inexperienced and experienced medical professionals as well as patients. Nature Publishing Group UK 2019-04-16 /pmc/articles/PMC6467991/ /pubmed/30992468 http://dx.doi.org/10.1038/s41598-019-42261-3 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Setty, Yaki eBrain: a Three Dimensional Simulation Tool to Study Drug Delivery in the Brain |
title | eBrain: a Three Dimensional Simulation Tool to Study Drug Delivery in the Brain |
title_full | eBrain: a Three Dimensional Simulation Tool to Study Drug Delivery in the Brain |
title_fullStr | eBrain: a Three Dimensional Simulation Tool to Study Drug Delivery in the Brain |
title_full_unstemmed | eBrain: a Three Dimensional Simulation Tool to Study Drug Delivery in the Brain |
title_short | eBrain: a Three Dimensional Simulation Tool to Study Drug Delivery in the Brain |
title_sort | ebrain: a three dimensional simulation tool to study drug delivery in the brain |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467991/ https://www.ncbi.nlm.nih.gov/pubmed/30992468 http://dx.doi.org/10.1038/s41598-019-42261-3 |
work_keys_str_mv | AT settyyaki ebrainathreedimensionalsimulationtooltostudydrugdeliveryinthebrain |